EUCTR2010-018320-10-NL进行中（未招募）不适用
An open-label extension of study AC-066A301 investigating the safety and tolerability of ACT-385781A in patients with pulmonary arterial hypertension (PAH) - EPITOME-2 Extension
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Signed informed consent prior to initiation of any study mandated procedure
- •2. Patients who completed participation in study AC 066A301
- •3. Patients who have not obtained access (i.e. reimbursement) to commercial EFI at the time of ending participation in study AC-066A301
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 36
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 4
排除标准
- •1. Patients who prematurely discontinued study drug in study AC-066A301
- •2. Patients for whom continued treatment with EFI is no longer considered appropriate
研究者
相似试验
进行中（未招募）
不适用
An extension of study AC-066A301 to investigate safety and tolerability of the study medication (epoprostenol for injection)Hipertension Arterial PulmonarMedDRA version: 14.0Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2010-018320-10-ESACTELION Pharmaceuticals Ltd40
已完成
3 期
An open-label extension of study AC-066A301 investigating the safety and tolerability of ACT-385781A in patients with pulmonary arterial hypertension (PAH)10037454Pulmonary arterial hypertensionNL-OMON39075Actelion Pharmaceuticals5
进行中（未招募）
不适用
An extension of study AC-066A301 to investigate safety and tolerability of the study medication (epoprostenol for injection)MedDRA version: 14.1Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersPulmonary Arterial HypertensionEUCTR2010-018320-10-BEACTELION Pharmaceuticals Ltd40
已完成
3 期
Epoprostenol for Injection in Patients With Pulmonary Arterial HypertensionPulmonary Arterial HypertensionNCT01470144Actelion41
已完成
4 期
Epoprostenol for Injection in Pulmonary Arterial Hypertension - Extension of AC-066A401Pulmonary Arterial HypertensionNCT01105117Actelion2